UPDATE: Intersect ENT (XENT) Posts Q2 Loss of $2.36/Share

(Updated - September 3, 2014 4:41 PM EDT)

Intersect ENT (Nasdaq: XENT) reported Q2 EPS of ($2.36), versus analyst estimate of ($2.59). Revenue for the quarter came in at $8.6 million versus the consensus estimate of $8.46 million.

For earnings history and earnings-related data on (XENT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c